193 related articles for article (PubMed ID: 11360195)
1. Cytoskeletal organization in tropomyosin-mediated reversion of ras-transformation: Evidence for Rho kinase pathway.
Shah V; Bharadwaj S; Kaibuchi K; Prasad GL
Oncogene; 2001 Apr; 20(17):2112-21. PubMed ID: 11360195
[TBL] [Abstract][Full Text] [Related]
2. Distinct involvement of cdc42 and RhoA GTPases in actin organization and cell shape in untransformed and Dbl oncogene transformed NIH3T3 cells.
Olivo C; Vanni C; Mancini P; Silengo L; Torrisi MR; Tarone G; Defilippi P; Eva A
Oncogene; 2000 Mar; 19(11):1428-36. PubMed ID: 10723134
[TBL] [Abstract][Full Text] [Related]
3. Possible involvement of the inactivation of the Rho-Rho-kinase pathway in oncogenic Ras-induced transformation.
Izawa I; Amano M; Chihara K; Yamamoto T; Kaibuchi K
Oncogene; 1998 Dec; 17(22):2863-71. PubMed ID: 9879992
[TBL] [Abstract][Full Text] [Related]
4. Suppression of src-induced transformed phenotype by expression of tropomyosin-1.
Prasad GL; Masuelli L; Raj MH; Harindranath N
Oncogene; 1999 Mar; 18(11):2027-31. PubMed ID: 10208425
[TBL] [Abstract][Full Text] [Related]
5. Suppression of neoplastic transformation and regulation of cytoskeleton by tropomyosins.
Shah V; Braverman R; Prasad GL
Somat Cell Mol Genet; 1998 Sep; 24(5):273-80. PubMed ID: 10696235
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the expression of tropomyosins and actin cytoskeleton by ras transformation.
Prasad GL
Methods Enzymol; 2006; 407():410-22. PubMed ID: 16757342
[TBL] [Abstract][Full Text] [Related]
7. RhoA effector mutants reveal distinct effector pathways for cytoskeletal reorganization, SRF activation and transformation.
Sahai E; Alberts AS; Treisman R
EMBO J; 1998 Mar; 17(5):1350-61. PubMed ID: 9482732
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of tropomyosin-2 expression in c-Jun-transformed rat fibroblasts involves induction of a MEK1-dependent autocrine loop.
Ljungdahl S; Linder S; Franzén B; Binétruy B; Auer G; Shoshan MC
Cell Growth Differ; 1998 Jul; 9(7):565-73. PubMed ID: 9690624
[TBL] [Abstract][Full Text] [Related]
9. Anti-oncogenic effects of tropomyosin: isoform specificity and importance of protein coding sequences.
Braverman RH; Cooper HL; Lee HS; Prasad GL
Oncogene; 1996 Aug; 13(3):537-45. PubMed ID: 8760295
[TBL] [Abstract][Full Text] [Related]
10. Loss of expression of tropomyosin-1, a novel class II tumor suppressor that induces anoikis, in primary breast tumors.
Raval GN; Bharadwaj S; Levine EA; Willingham MC; Geary RL; Kute T; Prasad GL
Oncogene; 2003 Sep; 22(40):6194-203. PubMed ID: 13679858
[TBL] [Abstract][Full Text] [Related]
11. FGF-2 induced reorganization and disruption of actin cytoskeleton through PI 3-kinase, Rho, and Cdc42 in corneal endothelial cells.
Lee HT; Kay EP
Mol Vis; 2003 Dec; 9():624-34. PubMed ID: 14685150
[TBL] [Abstract][Full Text] [Related]
12. Role of a signal transduction pathway which controls disassembly of microfilament bundles and suppression of high-molecular-weight tropomyosin expression in oncogenic transformation of NRK cells.
Masuda A; Takenaga K; Kondoh F; Fukami H; Utsumi K; Okayama H
Oncogene; 1996 May; 12(10):2081-8. PubMed ID: 8668333
[TBL] [Abstract][Full Text] [Related]
13. Resensitization of breast cancer cells to anoikis by tropomyosin-1: role of Rho kinase-dependent cytoskeleton and adhesion.
Bharadwaj S; Thanawala R; Bon G; Falcioni R; Prasad GL
Oncogene; 2005 Dec; 24(56):8291-303. PubMed ID: 16170368
[TBL] [Abstract][Full Text] [Related]
14. TIM, a Dbl-related protein, regulates cell shape and cytoskeletal organization in a Rho-dependent manner.
Xie X; Chang SW; Tatsumoto T; Chan AM; Miki T
Cell Signal; 2005 Apr; 17(4):461-71. PubMed ID: 15601624
[TBL] [Abstract][Full Text] [Related]
15. Effector domain mutants of Rho dissociate cytoskeletal changes from nuclear signaling and cellular transformation.
Zohar M; Teramoto H; Katz BZ; Yamada KM; Gutkind JS
Oncogene; 1998 Aug; 17(8):991-8. PubMed ID: 9747878
[TBL] [Abstract][Full Text] [Related]
16. Differential involvement of the integrin-linked kinase (ILK) in RhoA-dependent rearrangement of F-actin fibers and induction of connective tissue growth factor (CTGF).
Graness A; Giehl K; Goppelt-Struebe M
Cell Signal; 2006 Apr; 18(4):433-40. PubMed ID: 15970428
[TBL] [Abstract][Full Text] [Related]
17. TGFbeta3-induced activation of RhoA/Rho-kinase pathway is necessary but not sufficient for epithelio-mesenchymal transdifferentiation: implications for palatogenesis.
Kaartinen V; Haataja L; Nagy A; Heisterkamp N; Groffen J
Int J Mol Med; 2002 Jun; 9(6):563-70. PubMed ID: 12011971
[TBL] [Abstract][Full Text] [Related]
18. The insert region of RhoA is essential for Rho kinase activation and cellular transformation.
Zong H; Kaibuchi K; Quilliam LA
Mol Cell Biol; 2001 Aug; 21(16):5287-98. PubMed ID: 11463812
[TBL] [Abstract][Full Text] [Related]
19. Desensitization of the PDGFbeta receptor by modulation of the cytoskeleton: the role of p21(Ras) and Rho family GTPases.
Stice LL; Forman LW; Hahn CS; Faller DV
Exp Cell Res; 2002 Apr; 275(1):17-30. PubMed ID: 11925102
[TBL] [Abstract][Full Text] [Related]
20. Role of RhoA/ROCK-dependent actin contractility in the induction of tenascin-C by cyclic tensile strain.
Sarasa-Renedo A; Tunç-Civelek V; Chiquet M
Exp Cell Res; 2006 May; 312(8):1361-70. PubMed ID: 16448650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
